EMA Says Yes To GSK’s Belantamab But Rejects Tagraxofusp & Emapalumab

 
• By Neena Brizmohun

GlaxoSmithKline's first-of-its kind treatment for multiple myeloma is among 11 new medicines that have won an EU approval nod from the European Medicines Agency this week.

Concept of national healthcare system - EU - European Union
The EMA has this month recommended EU approval for a number of new drugs • Source: Shutterstock

More from Europe

More from Geography